search

Active clinical trials for "Carcinoma, Renal Cell"

Results 1581-1590 of 1644

Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States...

Kidney CancerRenal Cell Carcinoma

Incidence rates of renal cell cancer have increased rapidly in the U.S. and other countries. In particular, rates among African Americans have risen more sharply than any other cancer site. We propose to conduct a population-based case-control study of renal cell cancer in areas of the U.S. with a high proportion of African American residents. We will include two study centers and one data coordinating center and will recruit study participants over a period of four years. We plan to conduct in-person interviews with 2,100 cases (1,400 whites and 700 blacks) and 2,800 controls (1,400 each of whites and blacks) to elicit information on demographic background and history of exposures. A 40 ml blood sample will be collected from living cases and controls to measure certain environmental exposures and for genetic analyses. Two buccal cell samples will be collected from living cases and controls for genetic analyses. Tumor tissue blocks will be collected from as many cases as possible for assays of tumor mutations. Diagnostic slides will be collected for standardized reclassification of tumors into clear cell, papillary, and other histologic subtypes. Medical records for all cases will be reviewed for health insurance coverage, concomitant conditions, presenting symptoms, tumor stage, size and grade, and methods leading to diagnosis of renal cell cancer.

Completed5 enrollment criteria

The Incidence of Pulmonary Embolism During Nephrectomy

Pulmonary EmbolismRenal Cell Carcinoma1 more

Patients with renal carcinoma was reported at high incidence of perioperative pulmonary embolism from current study. The investigators aimed to determine the incidence and outcome of this group of patient in the tertiary-care, university hospital and the rate of intraoperative transesophageal echocardiography utility and outcome.

Completed2 enrollment criteria

Master Protocol to Study Treatment Patterns, Medication Adherence, Health and Economic Outcomes...

Renal Cell Carcinoma (RCC)

The study aims to assess treatment patterns and outcomes in advanced RCC patients in real world clinical practices across various real world databases. Four databases will be evaluated

Completed9 enrollment criteria

Complications Associated With Partial Nephrectomy for Renal Cancer

Renal CancerPartial Nephrectomy

This paper evaluates the initial complications and the complications two years postoperatively necessitating re-hospitalisation for three surgical procedures for renal tumour partial nephrectomy .

Completed3 enrollment criteria

Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma

Renal Cell Carcinoma

detection of Survivin expression in renal cell carcinoma and correlate this expression to tumor grade and stage.

Completed2 enrollment criteria

Cabozantinib Real-life Use for Advanced Renal Cell Carcinoma in France: a Retrospective Descriptive...

Renal Cell Carcinoma

The primary objective of the study is to describe the real-life conditions of use and exposure of cabozantinib in France in two cohorts defined by their treatment initiation period.

Completed3 enrollment criteria

Clinical and Histopathologic Characteristics of BAP1 Mutations

Malignant Pleural Mesothelioma (MPM)Choroidal Nevus4 more

The goal of this protocol is to determine the prevalence of somatic and germline mutations in BAP1 (BRCA associated protein-1) among patients with mesothelioma , choroidal nevus, primary uveal melanoma (UM), or metastatic UM seen at our institution.

Completed36 enrollment criteria

Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized...

Metastatic Renal Cancer

The purpose of this study is the evaluation of dynamic contrast-enhanced CT (Perfusion-CT) for therapeutic response predicition in patients with metastasized renal carcinoma (mRCC) undergoing antiangiogenetic therapy (AAT) with multikinase inhibitors. In this study patients with mRCC under AAT will be examined with 3 serial Perfusion - CT scans - partially intergrated in their regular staging CT scheme - at baseline (before AAT start), 1 week after AAT as well as 8 weeks after AAT initialization. Thereby selected intrabdomial or intrathoracic metastases will be monitored longitudinally with perfusion CT. Pretreament and post-treament perfusion characteristics of the assessed metastatic lesions will be quantified and correlated with patient outcome.

Completed12 enrollment criteria

MRI in Renal Tumors

Renal Cell Carcinoma

Diagnostic imaging for renal masses of unknown nature using conventional imaging modalities such as 3 phase contrast-enhanced computed tomography (CT) is not always conclusive. After (partial) nephrectomy, 10-20 % of the resected tumors show benign histology which could not be identified on diagnostic imaging. With improved imaging techniques available, leading to improvements in characterisation of renal tumors, the number of unnecessary resections may be reduced. The objective of this study is to assess the ability to discriminate oncocytoma from RCC based on the ADC distribution parameters with addition of, tumor volume, and patient demographic characteristics.

Completed7 enrollment criteria

Robot-Assisted Laparoscopic Radio Frequency Ablation Assisted Enucleation of Renal Cell Carcinoma...

Renal Cell Carcinoma

To evaluate the feasibility and efficiency of zero ischemia robot-assisted laparoscopic radio frequency ablation assisted enucleation of T1a renal cell carcinoma in comparison with robot-assisted laparoscopic partial nephrectomy without hilar clamping.

Unknown status9 enrollment criteria
1...158159160...165

Need Help? Contact our team!


We'll reach out to this number within 24 hrs